Transplantatoverlevelsen efter 12 måneder var 96, 7% for Advagraf, 92, 9% for Prograf og 95, 7% for ciclosporin.
12-month graft survival was 96.7% for Advagraf, 92.9% for Prograf and 95.7% for ciclosporin.